HK1180969A1 - Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster - Google Patents
Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zosterInfo
- Publication number
- HK1180969A1 HK1180969A1 HK13108347.8A HK13108347A HK1180969A1 HK 1180969 A1 HK1180969 A1 HK 1180969A1 HK 13108347 A HK13108347 A HK 13108347A HK 1180969 A1 HK1180969 A1 HK 1180969A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- herpes
- polyethylene glycol
- genitalis
- labialis
- zoster
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36232910P | 2010-07-08 | 2010-07-08 | |
| PCT/IB2011/001919 WO2012004669A1 (fr) | 2010-07-08 | 2011-07-08 | Compositions de polyéthylèneglycol pour lutter contre les rechutes d'herpès labial, d'herpès génital et de zona |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1180969A1 true HK1180969A1 (en) | 2013-11-01 |
Family
ID=44588123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13108347.8A HK1180969A1 (en) | 2010-07-08 | 2013-07-16 | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9814743B2 (fr) |
| EP (1) | EP2563374B1 (fr) |
| JP (1) | JP5858994B2 (fr) |
| KR (1) | KR101881175B1 (fr) |
| CN (1) | CN103079574B (fr) |
| AU (1) | AU2011275458B2 (fr) |
| CA (1) | CA2803228C (fr) |
| DK (1) | DK2563374T3 (fr) |
| ES (1) | ES2442928T3 (fr) |
| HK (1) | HK1180969A1 (fr) |
| HR (1) | HRP20140135T1 (fr) |
| IL (1) | IL223582A (fr) |
| MX (1) | MX2012014783A (fr) |
| PL (1) | PL2563374T3 (fr) |
| PT (1) | PT2563374E (fr) |
| RS (1) | RS53162B (fr) |
| RU (1) | RU2643763C2 (fr) |
| SG (1) | SG186937A1 (fr) |
| SI (1) | SI2563374T1 (fr) |
| WO (1) | WO2012004669A1 (fr) |
| ZA (1) | ZA201300177B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG186937A1 (en) | 2010-07-08 | 2013-02-28 | Devirex Ag | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| WO2013102885A1 (fr) | 2012-01-06 | 2013-07-11 | Devirex Ag | Compositions hygroscopiques pour lutter contre les rechutes d'herpès labial, d'herpès génital, et du zona herpétique |
| MX362459B (es) | 2013-02-19 | 2019-01-18 | Johnson & Johnson Consumer Inc | Metodos y composiciones para mejorar la apariencia y formacion de tejido de cicatrizacion. |
| EP2803354B1 (fr) * | 2013-05-14 | 2015-03-04 | NajöPharm GmbH i.G. | Combinaison de l'acide polyacrylique et du 2-amino-2-methylpropanol pour l'utilisation dans le traitement des infections de l'Herpès |
| WO2018095576A1 (fr) * | 2016-11-28 | 2018-05-31 | Aicuris Anti-Infective Cures Gmbh | Formulation pharmaceutique topique comprenant du n-[5-(aminosulfonyle)-4-méthyl-1,3-thiazol-2-yl]-n-méthyl-2-[4-(2-pyridinyl)-phényl]-acétamide |
| US20210330700A1 (en) * | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols |
| WO2021233571A1 (fr) * | 2020-04-30 | 2021-11-25 | Ninoderm Ug (Haftungsbeschränkt) | Agent de traitement pour thérapie antivirale, applicateur et procédé de fabrication d'un agent de traitement |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4603122A (en) * | 1979-08-17 | 1986-07-29 | Blough Herbert A | Antiviral agent against herpes virus infections |
| GB2080682B (en) * | 1980-07-30 | 1984-03-28 | Ciba Geigy Ag | Antiherpetically active lipstick |
| EP0087161A3 (fr) | 1982-02-24 | 1984-04-04 | Key Pharmaceuticals, Inc. | Médicament contenant du myristate d'isopropyle et un 4-alcoyle-2,6-(bis-tert.butyle)phénol |
| US5232700A (en) * | 1990-11-14 | 1993-08-03 | The Administrators Of The Tulane Educational Fund | Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient |
| NL9500216A (nl) | 1995-02-06 | 1996-09-02 | Bio Pharma Sciences Bv | Farmaceutische samenstelling voor de behandeling van herpes. |
| US6045823A (en) * | 1996-09-19 | 2000-04-04 | Dragoco Gerberding & Co. Ag | Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same |
| GB9902227D0 (en) * | 1999-02-01 | 1999-03-24 | Cipla Limited | Pharmaceutical composition for topical administration |
| US8030260B2 (en) * | 2005-03-25 | 2011-10-04 | Chemsil Silicones, Inc | Pre-shave compositions and methods of using same |
| DE202005007363U1 (de) | 2005-05-04 | 2005-07-14 | Anton Hübner GmbH & Co. KG | Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen |
| US20100111883A1 (en) | 2007-01-17 | 2010-05-06 | Peter Vitins | Cyclodextrin formulations |
| SG186937A1 (en) | 2010-07-08 | 2013-02-28 | Devirex Ag | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| WO2013102885A1 (fr) | 2012-01-06 | 2013-07-11 | Devirex Ag | Compositions hygroscopiques pour lutter contre les rechutes d'herpès labial, d'herpès génital, et du zona herpétique |
-
2011
- 2011-07-08 SG SG2013000823A patent/SG186937A1/en unknown
- 2011-07-08 US US13/704,061 patent/US9814743B2/en active Active
- 2011-07-08 PL PL11754919T patent/PL2563374T3/pl unknown
- 2011-07-08 KR KR1020137002574A patent/KR101881175B1/ko active IP Right Grant
- 2011-07-08 ES ES11754919.6T patent/ES2442928T3/es active Active
- 2011-07-08 AU AU2011275458A patent/AU2011275458B2/en active Active
- 2011-07-08 EP EP11754919.6A patent/EP2563374B1/fr active Active
- 2011-07-08 DK DK11754919.6T patent/DK2563374T3/da active
- 2011-07-08 PT PT117549196T patent/PT2563374E/pt unknown
- 2011-07-08 MX MX2012014783A patent/MX2012014783A/es active IP Right Grant
- 2011-07-08 RS RS20140058A patent/RS53162B/en unknown
- 2011-07-08 CA CA2803228A patent/CA2803228C/fr active Active
- 2011-07-08 CN CN201180033948.1A patent/CN103079574B/zh active Active
- 2011-07-08 WO PCT/IB2011/001919 patent/WO2012004669A1/fr active Application Filing
- 2011-07-08 JP JP2013517583A patent/JP5858994B2/ja active Active
- 2011-07-08 RU RU2013100383A patent/RU2643763C2/ru active
- 2011-07-08 SI SI201130086T patent/SI2563374T1/sl unknown
-
2012
- 2012-12-12 IL IL223582A patent/IL223582A/en active IP Right Grant
-
2013
- 2013-01-08 ZA ZA2013/00177A patent/ZA201300177B/en unknown
- 2013-07-16 HK HK13108347.8A patent/HK1180969A1/xx unknown
-
2014
- 2014-02-12 HR HRP20140135AT patent/HRP20140135T1/hr unknown
-
2017
- 2017-11-06 US US15/804,961 patent/US20180055875A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2012014783A (es) | 2013-04-03 |
| CN103079574A (zh) | 2013-05-01 |
| PT2563374E (pt) | 2014-01-23 |
| US20130090389A1 (en) | 2013-04-11 |
| ZA201300177B (en) | 2014-03-26 |
| JP5858994B2 (ja) | 2016-02-10 |
| ES2442928T3 (es) | 2014-02-14 |
| AU2011275458B2 (en) | 2014-11-27 |
| WO2012004669A1 (fr) | 2012-01-12 |
| RU2643763C2 (ru) | 2018-02-05 |
| CN103079574B (zh) | 2017-04-12 |
| SI2563374T1 (sl) | 2014-01-31 |
| EP2563374A1 (fr) | 2013-03-06 |
| KR101881175B1 (ko) | 2018-07-23 |
| US9814743B2 (en) | 2017-11-14 |
| AU2011275458A1 (en) | 2013-02-28 |
| SG186937A1 (en) | 2013-02-28 |
| PL2563374T3 (pl) | 2014-04-30 |
| US20180055875A1 (en) | 2018-03-01 |
| RU2013100383A (ru) | 2014-08-20 |
| KR20130142992A (ko) | 2013-12-30 |
| EP2563374B1 (fr) | 2013-11-13 |
| JP2013530208A (ja) | 2013-07-25 |
| CA2803228C (fr) | 2019-03-12 |
| DK2563374T3 (da) | 2014-01-20 |
| RS53162B (en) | 2014-06-30 |
| IL223582A (en) | 2017-12-31 |
| CA2803228A1 (fr) | 2012-01-12 |
| HRP20140135T1 (hr) | 2014-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1180969A1 (en) | Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster | |
| IL252517A0 (en) | Uracil derivatives as axl and c-met kinase inhibitors | |
| WO2011106105A9 (fr) | Inhibiteurs destinés à une utilisation antivirale | |
| ZA201204959B (en) | Pyrazole derivatives as jak inhibitors | |
| EP2706853A4 (fr) | Aminopyrimidines en tant qu'inhibiteurs de syk | |
| EP2632466A4 (fr) | Dérivés quinazoline, compositions et utilisations correspondantes | |
| EP2552214A4 (fr) | Pyrazolyl-pyrimidines utilisés en tant qu'inhibiteurs de kinase | |
| SI2627631T1 (sl) | Pirolidinoni kot zaviralci metap2 | |
| EP2547334A4 (fr) | Nouveaux composés et compositions pour le ciblage de cellules souches cancéreuses | |
| EP2694521A4 (fr) | Composés de dioxyde de thiadiazine fusionnée à la pyrrolidine en tant qu'inhibiteurs de bace, compositions et leur utilisation | |
| PL2730679T3 (pl) | Bezchromowe kompozycje ceramiczne na bazie krzemianu | |
| SI2606034T1 (sl) | Pirimidinski derivati kot inhibitorji fak | |
| RS58945B1 (sr) | Derivati benzodioksola kao inhibitori fosfodiesteraze | |
| ZA201406038B (en) | Substituted pyrimidine compounds and their use as syk inhibitors | |
| EP2652055A4 (fr) | Composition de peinture hybride organique-inorganique | |
| GB201109094D0 (en) | Indexable insert | |
| SG10201704745UA (en) | Novel compounds and compositions for targeting cancer stem cells | |
| ZA201501812B (en) | Nootropic compositions for improving memory performance | |
| EP2907856A4 (fr) | Composition de primaire à base d'eau | |
| IL233542A0 (en) | Morpholinyl derivatives as 2-mogat inhibitors | |
| EP2566484A4 (fr) | Compositions contenant des nucléosides puriques et pyrimidiniques, des peptides, et du manganèse, et utilisations associées | |
| PL2729523T3 (pl) | Kompozycje polimerowe oparte na etylenie | |
| HK1183030A1 (zh) | 抗病毒的雜環化合物 | |
| PL2686378T3 (pl) | Kompozycje na bazie polietylenu | |
| EP2844642B8 (fr) | Composés pour inhiber la prolifération cellulaire dans les cancers induits par l'egfr |